two
recombin
fipv
spike
protein
assess
immunogen
properti
kitten
challeng
intranas
fipv
humor
respons
assess
elisa
serum
neutralis
test
chang
pbmc
cytokin
mrna
level
detect
revers
transcript
semiquantit
polymeras
chain
reaction
assay
rtsqpcr
assess
ifng
kitten
develop
clinic
sign
typic
fip
confirm
gross
post
mortem
examin
recombin
protein
induc
littl
specif
antibodi
respons
prior
challeng
fail
alter
cours
diseas
compar
control
one
week
viru
challeng
stimul
pbmc
show
small
increas
express
ifng
mrna
correl
transient
pyrexia
time
express
mrna
remain
unalt
fip
develop
mrna
level
ifng
becam
markedli
depress
felin
infecti
periton
fip
immunemedi
usual
fatal
diseas
domest
exot
felid
diseas
present
fibrin
seros
accumul
highli
proteinac
fluid
within
bodi
caviti
dissemin
pyogranulomata
format
hypergammaglobulinaemia
format
immun
complex
review
pedersen
caus
infect
certain
variant
veterinari
immunolog
immunopatholog
felin
coronaviru
pedersen
vennema
et
al
herrewegh
et
al
pathogenesi
diseas
complex
cell
mediat
immun
cmi
play
protect
role
humor
respons
gener
detriment
aid
viral
dissemin
opsonis
uptak
macrophag
result
immun
complex
ic
format
weiss
scott
pedersen
ic
deposit
small
blood
vessel
fix
activ
complement
becom
phagocytos
macrophag
weiss
scott
infect
macrophag
promot
immunemedi
tissu
reaction
via
interact
alter
cell
membran
complementfix
antibodi
cytotox
tcell
degener
infect
macrophag
lead
releas
new
viru
complement
compon
jacobsegeel
et
al
weiss
scott
jacobsegeel
horzinek
viciou
cycl
complementmedi
vascular
damag
ensu
gener
chemotact
complement
compon
attract
neutrophil
releas
proteolyt
enzym
lead
tissu
damag
reaction
seen
degen
prolif
chang
blood
vessel
wall
particularli
endotheli
medial
layer
small
vein
arteri
periton
pleural
serosa
interstiti
connect
tissu
parenchymat
organ
hayashi
et
al
jacobsegeel
et
al
weiss
scott
b
cytokin
intim
involv
control
immun
reaction
mosmann
coffman
romagnani
yet
known
cytokin
particular
import
develop
fip
postul
diseas
progress
increas
product
possibl
typic
cytokin
reduc
product
andor
interferon
g
ifng
typic
cytokin
may
result
decreas
protect
cmi
increas
nonprotect
antibodi
respons
evid
support
come
studi
show
clinic
fip
associ
markedli
increas
express
within
lymphoid
tissu
dean
et
al
usual
classifi
cytokin
fip
also
associ
high
level
sera
ascit
fluid
goitsuka
et
al
cytokin
secret
fcovinfect
macrophag
within
granulomata
periton
exud
goitsuka
et
al
goitsuka
et
al
goitsuka
et
al
hasegawa
hasegawa
also
produc
along
vascular
endothelium
within
area
vascular
damag
carvalho
savag
presenc
polaris
naiv
th
cell
effector
cell
induc
initi
product
tcell
rincon
et
al
act
synergi
stimul
b
cell
activ
induc
nonprotect
hypergammaglobulinaemia
seen
commonli
clinic
fip
maggi
et
al
spark
et
al
clerici
shearer
increas
level
plasma
leukotrien
prostaglandin
also
seen
associ
clinic
fip
weiss
et
al
favour
develop
respons
augment
product
berger
et
al
inhibit
product
cytokin
dendrit
cell
ifng
tcell
van
der
pouw
kraan
et
al
hilken
et
al
taken
togeth
find
support
hypothesi
fip
diseas
number
result
disagr
conclus
includ
mild
elev
within
spleen
reduc
level
within
thymu
minim
chang
tnf
dean
et
al
twelv
old
specif
pathogenfre
spf
kitten
obtain
commerci
supplier
hous
pathogenfre
quarter
kitten
divid
three
group
one
left
control
control
one
immunis
recombin
fipv
spike
protein
third
immunis
recombin
modifi
spike
protein
three
major
enhanc
epitop
delet
sdad
recombin
protein
obtain
cotransfect
cell
bacpac
baculoviru
linear
dna
baculoviru
transfer
plasmid
pbacpac
contain
fipv
code
sequenc
protein
administ
subcutan
carbopol
adjuv
given
three
separ
occas
apart
kitten
challeng
oronas
ccid
week
final
immunis
daili
health
check
perform
day
challeng
includ
take
rectal
temperatur
assess
kitten
evid
inappet
depress
dyspnoea
ascit
jaundic
lymphadenopathi
diarrhoea
ocular
nasal
discharg
oral
nasal
ulcer
hypersaliv
conjunct
sneez
neurolog
sign
serial
blood
sampl
collect
assess
serolog
respons
monitor
stimul
peripher
blood
mononuclear
cell
pbmc
cytokin
mrna
level
viru
neutralis
test
perform
well
flat
bottom
microtit
tm
plate
costar
usa
use
doubl
dilut
serum
serum
sampl
assess
quadruplet
well
sampl
mix
equal
volum
cell
growth
medium
eagl
minimum
essenti
medium
mem
sigma
supplement
vv
foetal
bovin
serum
sigma
wv
sodium
bicarbon
vv
nonessenti
amino
acid
gibcobrl
vv
lactalbumin
hydrolys
gibcobrl
mm
lglutamin
mgml
gentamicin
contain
fipv
incub
min
whole
felin
embryo
wfe
cell
ad
cultur
incub
four
day
titr
express
reciproc
dilut
complet
neutralis
fipv
serum
fcovspecif
igg
detect
use
elisa
method
ninetysix
well
microtit
tm
plate
dynatech
laboratori
usa
coat
overnight
ml
sucros
gradientpurifi
fipv
carbonatebicarbon
coat
buffer
voller
et
al
plate
wash
five
time
vv
tween
doubl
dilut
seri
serum
sampl
ad
plate
incub
h
room
temperatur
wash
mous
anticat
igg
monoclon
antibodi
gift
dr
k
haverson
univers
bristol
uk
ad
optimum
dilut
vv
tween
plate
incub
min
room
temperatur
incub
wash
repeat
goat
antimousealkalin
phosphataseconjug
monoclon
antibodi
sigma
ad
dilut
plate
incub
min
room
temperatur
wash
paranitrophenol
phosphat
mgml
ad
carbon
bicarbon
coat
buffer
reaction
allow
progress
min
stop
ad
ml
vv
sulphur
acid
titr
express
reciproc
highest
dilut
serum
give
optic
densiti
od
least
twice
standard
neg
serum
blood
sampl
centrifug
min
plasma
remov
store
prior
assess
antibodi
respons
fcov
see
buffi
coat
cell
dilut
ml
spb
overlaid
onto
ml
ficollpaqu
pharmacia
biotech
ml
conic
tube
centrifug
min
room
temperatur
cell
collect
interfac
transfer
fresh
tube
wash
twice
spb
resuspend
cell
per
ml
lymphocyt
growth
medium
rpmi
sigma
supplement
vv
foetal
bovin
serum
sigma
vv
hepe
mgml
glutamin
mgml
gentamicin
con
mgml
separ
cell
consist
greater
lymphocyt
viabil
determin
trypan
blue
exclus
cell
cultur
ml
aliquot
tissu
cultur
plate
costar
usa
h
cultur
adher
nonadher
cell
harvest
nonadher
cell
transfer
directli
fresh
tube
wash
twice
spb
pellet
ml
tri
reagent
sigma
ad
cultur
well
lyse
adher
cell
pipet
repeatedli
transfer
tube
contain
correspond
cell
pellet
repeat
gentl
pipet
ensur
complet
cell
lysi
prior
storag
rna
extract
use
ml
tri
reagent
per
cell
cell
lyse
repeat
pipet
lysat
chang
viscou
wateri
consist
lysat
vortex
prior
ad
ml
hplc
grade
chloroform
sigma
sampl
vortex
centrifug
min
hettich
zentrifugen
upper
aqueou
layer
transfer
fresh
ml
microcentrifug
tube
equival
volum
ml
cold
isopropanol
sigma
ad
sampl
vortex
chill
least
min
prefer
greater
h
chill
sampl
centrifug
min
supernat
discard
rna
pellet
wash
ad
ml
ethanol
molecular
grade
hayman
vortex
centrifug
ten
minut
supernat
discard
rna
dri
briefli
air
prior
resuspend
diethylpyrocarbon
depc
treat
water
ml
per
cell
equival
amount
rna
extract
vari
mg
per
cell
ratio
rna
dnase
treat
aliquot
rna
solut
heat
min
chill
quickli
ice
reaction
mixtur
adjust
contain
mgml
total
rna
mm
trishcl
ph
mm
kcl
mm
mgcl
uml
dnase
molecular
biolog
grade
gibco
brl
depctreat
water
final
volum
ml
mixtur
incub
min
room
temperatur
termin
reaction
mm
edta
ad
mixtur
incub
min
perform
revers
transcript
rna
solut
contain
mg
total
rna
incub
mg
oligodeoxythymidin
triphosph
dt
primer
min
chill
quickli
ice
least
min
sampl
adjust
addit
reagent
follow
condit
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
deoxynucl
acid
triphosph
dntp
mix
mm
dtt
uml
superscript
ii
rt
revers
transcriptas
gibcobrl
total
volum
ml
sampl
incub
min
heat
inactiv
min
chill
ice
sampl
treat
uml
ecoli
rnase
h
incub
min
cdna
either
use
directli
pcr
reaction
store
prior
process
primer
design
felin
housekeep
gene
dehydrogenas
sequenc
cytokin
primer
sequenc
use
initi
design
rottman
et
al
base
publish
sequenc
cozzi
et
al
bradley
et
al
ohashi
et
al
number
primer
redesign
base
new
publish
data
forward
f
revers
r
r
ifng
r
shown
tabl
schijn
et
al
ifng
argyl
et
al
schijn
et
al
start
studi
nucleic
acid
sequenc
felin
avail
synthesis
primer
highli
conserv
subunit
consensu
sequenc
man
macaqu
mous
pig
cow
determin
use
genbank
databas
primer
sequenc
f
r
shown
tabl
potenti
site
pcr
primer
identifi
consensu
sequenc
align
use
comput
assist
macvector
tm
kodak
primer
made
genosi
compon
first
round
pcr
reaction
combin
togeth
master
mix
adjust
give
reaction
condit
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dntp
mix
uml
taq
dna
polymeras
amplitaq
gold
tm
perkin
elmer
ml
vv
cdna
solut
mm
primer
depctreat
water
ad
make
final
volum
ml
order
studi
larg
number
sampl
pcr
perform
use
polycarbon
plate
format
temperatur
cycler
heat
lid
touchdown
hybaid
optimis
pcr
protocol
detect
messag
consist
initi
incub
min
follow
cycl
melt
min
anneal
min
extens
min
singl
extens
min
ifng
optimis
protocol
consist
initi
incub
min
follow
cycl
min
min
min
singl
extens
min
control
incorpor
set
pcr
reaction
posit
control
includ
amplifi
cdna
gener
kit
suppli
rna
use
kit
suppli
pcr
primer
later
use
experiment
cdna
sampl
known
give
strong
posit
result
neg
control
establish
cytokin
estim
includ
rt
primer
cdna
control
demonstr
probe
detect
singl
specif
band
pcr
product
appli
directli
nylon
membran
hybond
tm
n
amersham
prior
detect
use
enhanc
chemiluminesc
detect
system
ecl
tm
amersham
life
scienc
pcr
product
denatur
use
thermal
cycler
touchdown
hybaid
min
chill
quickli
ice
three
microlitr
denatur
pcr
product
appli
directli
nylon
membran
air
dri
fix
uv
cross
link
uv
transillumin
uvp
cambridg
uk
oligonucleotid
probe
design
use
comput
assist
macvector
tm
kodak
accord
publish
sequenc
ifng
felin
sequenc
help
unpublish
consensu
sequenc
man
macaqu
mous
pig
cow
tabl
probe
made
genosi
label
detect
oligonucleotid
probe
perform
use
ecl
holigolabel
detect
system
procedur
perform
follow
manufactur
recommend
oligonucleotid
probe
label
give
final
probe
concentr
mm
blot
prehybridis
two
eight
hour
label
probe
ad
ngml
hybridis
buffer
wv
kitsuppli
hybridis
buffer
compon
wv
sd
dilut
kitsuppli
liquid
block
hybridis
perform
h
membran
wash
direct
unbound
probe
remov
incub
twice
excess
stringenc
buffer
wv
sd
min
membran
rins
block
conjug
excess
conjug
remov
signal
gener
per
manufactur
recommend
luminesc
imag
detect
autoradiographi
film
hyperfilm
tm
eclamersham
film
expos
min
prior
develop
gbx
develop
replenish
kodak
fixat
gbx
fixer
replenish
kodak
allow
comparison
sampl
necessari
relat
amount
start
materi
detect
product
accomplish
protocol
standardis
measur
made
mani
step
possibl
pbmc
incub
fix
concentr
concentr
extract
rna
determin
spectrophotometri
ultrospec
ii
lkb
biochrom
one
unit
optic
densiti
nm
equival
approxim
mg
singl
strand
rna
ausubel
et
al
total
rna
isol
mg
optic
densiti
dilut
volum
ml
control
variat
rtpcr
housekeep
gene
involv
glycolysi
select
intern
control
mrna
assess
time
cytokin
follow
amplif
rtpcr
product
dot
onto
membran
duplic
control
variat
label
procedur
sampl
particular
cytokin
analys
simultan
autoradiograph
imag
quantifi
densitometri
use
model
imag
densitomit
biorad
laboratori
uk
molecular
analysi
softwar
version
macintoshbiorad
laboratori
uk
calcul
mean
rel
optic
densiti
od
correspond
volum
dot
multipli
densiti
background
densiti
subtract
duplic
dot
valu
averag
signal
use
control
variat
quantiti
rna
sampl
effici
rtpcr
use
cdna
known
give
strong
signal
dilut
seri
perform
determin
relationship
product
templat
rel
densiti
plot
linear
regress
correl
perform
result
express
cytokin
mrna
ratio
cdna
sampl
repres
singl
time
point
individu
cat
cat
consid
group
valu
averag
standard
deviat
calcul
graph
log
cytokin
mrna
ratio
adjust
zero
start
experi
later
valu
express
chang
rel
time
point
statist
analysi
perform
use
anova
bonferroni
post
test
relationship
od
concentr
pcr
product
analys
use
pearson
correl
coeffici
protein
well
toler
abnorm
sign
develop
kitten
period
prior
viru
challeng
week
challeng
kitten
develop
transient
pyrexia
defin
temperatur
return
normal
pyrexia
reappear
clinic
diseas
becam
appar
fig
within
week
challeng
kitten
develop
clinic
sign
typic
fip
fig
characteris
ascit
dyspnoea
occasion
sign
includ
sneez
hypersaliv
diarrhoea
none
group
show
acceler
develop
diseas
kitten
euthanas
becam
anorex
depress
subject
gross
post
mortem
examin
show
typic
lesion
consist
granulomata
viscer
organ
mani
also
periton
pleural
exud
kitten
seroneg
fcov
start
studi
neutralis
antibodi
detect
challeng
three
week
follow
challeng
kitten
develop
low
moder
neutralis
antibodi
titr
rose
euthanasia
fig
indic
anamnest
respons
immunis
group
compar
unimmunis
control
group
serum
antifcov
igg
antibodi
detect
first
immunis
kitten
develop
low
level
antibodi
second
dose
protein
administ
titr
alter
littl
third
immunis
rose
follow
challeng
continu
increas
euthanasia
fig
indic
anamnest
respons
immunis
group
compar
unimmunis
control
group
pcr
protocol
optimis
ensur
cytokin
assess
prodct
gener
singl
band
agaros
gel
ran
expect
molecular
weight
fig
thirti
thirtyf
pcr
cycl
shown
within
linear
phase
amplif
determin
assess
replic
tube
run
multipl
five
cycl
titrat
cdna
templat
prior
amplif
reveal
linear
relationship
amount
templat
ad
intens
result
autoradiograph
imag
intens
product
shown
proport
logarithm
templat
concentr
fig
cytokin
assay
found
compromis
dna
contamin
confirm
run
rtpcr
control
remov
dnase
step
rtpcr
control
fail
gener
product
band
remov
dnase
step
effect
product
cytokin
rtpcr
reaction
produc
singl
band
expect
molecular
weight
albeit
rather
weak
case
rtpcr
reaction
fail
gener
visibl
product
nortpcr
reaction
produc
faint
band
molecular
weight
seen
correspond
rtpcr
southern
blot
ecl
label
confirm
specif
band
rtpcr
reaction
reveal
band
cytokin
rtpcr
control
also
confirm
specif
band
rtpcr
control
express
band
appear
due
contamin
genom
dna
fig
rtpcr
product
run
ethidium
bromid
stain
gel
rtpcr
product
lane
product
gener
pbmc
separ
spf
cat
lane
product
kitsuppli
rna
control
lane
marker
b
rtpcr
product
lane
marker
lane
product
nine
spf
cat
c
rtpcr
product
lane
product
four
spf
cat
rtpcr
product
lane
product
six
spf
cat
lane
marker
e
rtpcr
product
lane
marker
lane
product
kitsuppli
rna
control
lane
product
nine
spf
cat
f
ifng
rtpcr
product
lane
marker
lane
product
six
spf
cat
g
rtpcr
product
lane
product
six
spf
cat
unaffect
dnase
treatment
sinc
shown
dnase
treatment
fail
alter
product
gener
step
incorpor
later
studi
due
kitten
small
size
possibl
collect
suffici
blood
assess
pbmc
cytokin
mrna
start
experi
first
cytokin
assess
therefor
occur
trial
second
immunis
viral
challeng
cdna
gener
rna
extract
blood
taken
day
challeng
kitten
number
individu
pcr
reaction
also
fail
gener
product
includ
post
challeng
reaction
kitten
kitten
day
euthanasia
sampl
kitten
pcr
amplif
denatur
pcr
product
sampl
pertain
individu
cytokin
dot
onto
singl
membran
label
en
mass
fig
ethidium
bromidestain
gel
autoradiograph
logarithm
plot
show
relationship
templat
concentr
intens
rtpcr
product
rna
extract
pbmc
spf
cat
pcr
run
use
primer
ethidium
bromidestain
gel
load
rtpcr
product
lane
product
gain
undilut
templat
lane
seriallydilut
templat
b
autoradiograph
blot
rtpcr
product
dot
undilut
templat
dot
twofold
seriallydilut
templat
dot
seriallydilut
templat
c
logarithm
plot
rel
od
autoradiograph
shown
b
analys
use
pearson
correl
coeffici
ecl
result
graph
fig
challeng
day
challeng
express
mrna
increas
slightli
trend
also
seen
mrna
express
mrna
slightli
reduc
day
challeng
euthanasia
mrna
level
significantli
reduc
downward
trend
also
follow
ifng
cytokin
fall
preced
small
rise
challeng
obvious
control
group
overal
mrna
level
remain
unchang
diseas
progress
cytokin
mrna
level
show
quit
mark
variat
individu
kitten
littl
evid
immunis
effect
statist
signific
differ
three
treatment
group
show
suppress
ifng
mrna
level
challeng
look
level
individu
kitten
two
basic
pattern
emerg
major
show
elev
express
least
initi
three
kitten
no
elev
fig
interestingli
three
earliest
kitten
show
evid
clinic
diseas
numer
attempt
made
develop
suitabl
vaccin
fip
unfortun
fail
number
activ
enhanc
diseas
wood
pedersen
pedersen
black
barlough
pedersen
et
al
pedersen
floyd
barlough
stoddart
gerber
et
al
scott
et
al
scott
et
al
enhanc
occur
earlier
onset
clinic
sign
higher
mortal
result
presenc
antibodi
fcov
prior
virul
challeng
weiss
scott
c
pedersen
antibodi
depend
enhanc
ade
probabl
result
antibodymedi
opsonis
infect
improv
phagocytosi
immun
complex
macrophag
acceler
lysi
virusinfect
cell
weiss
scott
gener
spike
protein
stimul
product
neutralis
enhanc
antibodi
spaan
et
al
refer
therein
vennema
et
al
hohdatsu
et
al
olsen
et
al
olsen
et
al
corapi
et
al
corapi
et
al
although
exact
relationship
enhanc
neutralis
epitop
remain
determin
number
attempt
made
develop
suitabl
subunit
vaccin
success
seen
murin
mhv
system
flori
et
al
flori
et
al
brown
et
al
cat
recombin
vaccinia
vector
express
fcov
ccv
tgev
protein
gener
caus
enhanc
diseas
rather
protect
vennema
et
al
chalmer
et
al
recent
work
tri
defin
exact
locat
neutralis
enhanc
epitop
hohdatsu
et
al
corapi
et
al
corapi
et
al
olsen
et
al
olsen
et
al
kitten
group
studi
experienc
clinic
time
cours
similar
seen
previou
experi
use
seroneg
kitten
virul
fcov
challeng
hayashi
et
al
pedersen
et
al
stoddart
et
al
vennema
et
al
mean
rectal
temperatur
curv
also
similar
seen
previous
fever
spike
week
follow
challeng
time
temperatur
return
normal
prior
persist
pyrexia
develop
alongsid
develop
clinic
sign
weiss
scott
vennema
et
al
vaccin
use
studi
fail
gener
immun
respons
remain
unclear
previous
baculoviru
system
success
gener
biolog
activ
felin
protein
includ
ifng
sakurai
et
al
argyl
et
al
produc
felin
viral
protein
immunogen
cat
env
gag
protein
fiv
lutz
et
al
berlinski
et
al
mice
felin
herpesviru
hemagglutinin
maeda
et
al
carbopol
adjuv
success
use
number
vaccin
studi
gualandi
et
al
mumford
et
al
sinc
protein
current
studi
induc
low
level
igg
neutralis
may
present
inappropri
perhap
incorrectli
fold
previou
studi
felin
cytokin
transcript
shown
peak
express
felin
cytokin
occur
h
stimul
con
goitsuka
et
al
rottman
et
al
rottman
et
al
con
put
tcell
mitogen
tend
use
sinc
felin
lymphocyt
respond
poorli
pha
lp
respond
well
con
schultz
adam
rottman
et
al
felin
macrophag
respond
stimul
lp
lin
bowman
optim
dose
con
determin
mgml
goitsuka
et
al
rottman
et
al
prior
stimul
felin
mrna
readili
detect
cozzi
et
al
tnf
appear
express
constitut
low
level
rottman
et
al
howev
sinc
latter
cytokin
synthesis
monocyt
macrophag
low
level
express
may
result
cell
activ
process
rottman
et
al
stimul
con
felin
pbmc
readili
produc
mrna
ifng
tnf
cozzi
et
al
rottman
et
al
studi
confirm
find
cytokin
except
tnf
assess
studi
analys
unfraction
human
pbmc
tnf
found
abund
cytokin
secret
includ
circul
monocyt
granulocyt
hagiwara
et
al
less
abund
cytokin
includ
ifng
came
mainli
tcell
major
sourc
ifng
individu
although
other
appear
secret
either
cell
zhou
et
al
hagiwara
et
al
disagr
find
tnf
normal
difficult
detect
unstimul
pbmc
cultur
aljanadi
et
al
reason
discrep
may
relat
inadvert
activ
monocyt
isol
process
sinc
separ
pbmc
hyperosmolar
solut
ficollhypaqu
cultur
ex
vivo
may
modifi
pbmc
function
de
groot
et
al
stimul
pha
fail
alter
product
tnf
caus
signific
increas
ifng
probabl
aros
tcell
mitogen
posit
effect
primari
sourc
along
also
secret
ifng
howev
tcell
mitogen
unabl
affect
monocyt
main
sourc
product
human
hagiwara
et
al
unlik
situat
mice
come
result
show
rtsqpcr
use
success
detect
cytokin
mrna
express
stimul
pbmc
monitor
rel
chang
cytokin
express
time
express
cytokin
mrna
necessarili
correl
precis
product
function
protein
mrna
express
protein
level
usual
follow
similar
trend
rottman
et
al
current
studi
demonstr
cytokin
mrna
level
express
stimul
pbmc
chang
kitten
challeng
small
increas
ifng
express
seen
week
follow
challeng
express
stay
fairli
constant
express
cytokin
becam
significantli
reduc
initi
increas
correspond
initi
fever
spike
sinc
pyrogen
possibl
two
event
link
hell
et
al
sourc
possibl
ifng
virusinfect
monocyt
macrophag
clinic
sign
ill
aris
viral
challeng
gener
depress
cytokin
express
seen
earli
progress
clinic
sign
develop
consist
find
seen
lymphoid
tissu
cat
fip
chang
cytokin
product
occur
rapidli
virul
challeng
dean
et
al
interestingli
chang
seen
studi
fulli
agre
studi
overal
theori
fip
diseas
apart
studi
demonstr
overal
immunosuppress
reduc
express
cytokin
monocytesmacrophag
tcell
ifng
fip
previous
shown
suppress
blastogen
respons
con
pbmc
lymphocyt
affect
lymph
node
haagman
et
al
reduc
express
seen
felin
viral
diseas
includ
felv
infect
goitsuka
et
al
lymphocyt
apoptosi
lymphopenia
may
respons
lack
tcell
cytokin
express
pbmc
reduc
express
monocytemacrophag
cytokin
may
perhap
relat
exhaust
dysfunct
dean
et
al
demonstr
increas
within
lymphoid
tissu
small
increas
within
spleen
reduc
level
within
thymu
howev
difficult
correl
find
present
studi
sinc
tissu
sampl
rather
pbmc
assess
result
requir
consider
activ
seen
plasma
healthi
cat
goitsuka
et
al
markedli
increas
plasma
ascit
fluid
cat
fip
goitsuka
et
al
may
expect
circul
monocyt
would
express
cytokin
high
level
jirik
et
al
sironi
et
al
studi
appear
case
said
sinc
express
monocytederiv
cytokin
depress
studi
overal
level
remain
constant
overal
express
may
enhanc
degre
evid
gener
mainli
outsid
blood
stream
come
studi
show
secret
fcovinfect
macrophag
within
granulomata
periton
exud
diffus
circul
goitsuka
et
al
goitsuka
et
al
goitsuka
et
al
goitsuka
et
al
hasegawa
hasegawa
case
kitten
particular
interest
three
earliest
kitten
show
evid
clinic
diseas
case
fail
show
elev
express
point
challeng
signific
find
remain
unclear
cat
fip
show
overal
lymphopenia
apoptosi
tcell
deplet
lymphoid
organ
spleen
mesenter
lymph
node
sever
affect
apoptosi
seen
tand
bcell
area
lymphoid
organ
plu
omentum
pyogranulomata
thymu
although
yet
proven
apoptot
cell
tcell
virtual
remov
tcell
affect
tissu
togeth
thymu
atrophi
argu
like
tcell
die
rather
bcell
stoddart
pedersen
haagman
et
al
particularli
given
apoptosi
occur
face
hypergammaglobulinaemia
immun
complex
format
jacobsegeel
et
al
spark
et
al
haagman
et
al
apoptosi
occur
result
releas
solubl
mediat
virusinfect
monocytesmacrophag
neutrophil
rather
viral
infect
lymphocyt
per
se
exact
natur
solubl
factor
still
determin
known
involv
tnf
transform
growth
factor
tgf
haagman
et
al
result
show
profound
reduct
pbmc
cytokin
express
evid
immunosuppress
natur
diseas
